Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare Disorders

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue depicts the current landscape and the new trends in a series of developments associated with drug discovery and development, including manufacturing for optimal drug delivery, across cancer research, autoimmune diseases, and rare disorders. The technologies incorporated in this study are related to cancer stem cells for cancer therapeutics, mammalian multi-protein clusters for drug discovery, and multi-biomarkers tests for autoimmune diseases. Special emphasis has been made on  biomanufacturing capabilities for drug delivery through precision particle fabrication.

Keywords: cancer stem cells, antitumor drug, mammalian genetic model, metastatic adenocarcinoma, rheumatoid arthritis, lysosomal acid, lipase deficiency, bilateral otitis media, encapsulation, liposome, microparticle, microsphere, microcapsule, precision particle fabrication

Table of Contents

Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare DisordersInnovations in drug delivery, across cancer, autoimmune diseases, and rare disordersDrug Discovery Platform to Target Cancer Stem Cells Multi-Biomarker Blood Test for Rheumatoid Arthritis Precision Encapsulation for Optimal Drug DeliveryMulti-Protein Clusters as Novel Drug Discovery ToolsNew Treatment for Patients with Lysosomal Acid Lipase Deficiency- Treatment for Bilateral Otitis Media Gets FDA NodNew Treatment Option for Metastatic Adenocarcinoma of PancreasAppendixPatent AnalysisPatent Analysis (continued)Industry Interactions




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.